Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Active Hexose Correlated Compound (AHCC) is a proprietary extract derived from shiitake mushroom mycelia. AHCC is primarily researched for its potential to modulate immune function, including enhancing natural killer (NK) cell activity, dendritic cell function, and cytokine production. In the context of Epstein-Barr Virus (EBV), which persists in the body and is associated with various chronic conditions, immune modulation is considered a plausible avenue for supportive therapy.

There is limited but suggestive scientific evidence supporting AHCC's use for EBV. Several in vitro and animal studies have demonstrated that AHCC can enhance immune responses against viral infections generally, including those caused by herpesviruses, of which EBV is a member. For example, animal research has shown increased NK cell activity and improved viral clearance with AHCC supplementation. However, direct clinical studies on AHCC for Epstein-Barr Virus in humans are lacking. Some case reports and preliminary open-label studies suggest benefit in viral load reduction and symptom improvement in chronic viral infections, but these are not specific or robust enough for EBV.

In summary, while there is a scientific rationale and some early evidence for AHCC's immune-boosting effects that could potentially aid in managing EBV, direct human clinical evidence is currently insufficient. Therefore, the evidence rating is moderate but not strong, meriting further research to clarify efficacy and safety specifically for Epstein-Barr Virus.

More about AHCC
More about Epstein Barr Virus

Other ingredients used for Epstein Barr Virus

Other health conditions supported by AHCC

Products containing AHCC